Sage Journals: Discover world-class research

Abstract

Background

Systemic artery-to-pulmonary artery (SA-PA) shunts provide effective palliation for complex congenital heart disease (CHD) but carry a risk for morbidity and mortality. We aimed to comprehensively analyze our experience with SA-PA shunts.

Methods

Our institutional Society of Thoracic Surgeons (STS) database was queried to identify patients who underwent SA-PA shunts from 2009 to 2022, excluding those who underwent the Norwood procedure, right ventricle-PA shunt, or fenestrated patch. Definitions from the STS Congenital Heart Surgery Database Specifications were used. Shunt failure included dysfunction secondary to thrombosis, obstruction, stenosis, or outgrowth requiring intervention.

Results

A total of 287 patients met inclusion criteria. Shunts were placed at a median of 15.0 days (interquartile range 7.0-39.5). A thoracotomy approach was used in 178 out of 287 patients (62.0%), and cardiopulmonary bypass was employed in only 46 of 287 cases (16.0%). Survival to the next stage was 89.5% (246/275), with in-hospital mortality of 6.3% (18/287) and interstage mortality of 4.2% (12/287). Shunt failure occurred in 54/287 (18.8%), and 77/287 (26.8%) required reintervention for shunt-related complications. On multivariable analysis, poorer shunt failure-free survival was associated with any syndrome, left-sided arch vessel shunt origin, concurrent complex repairs, competitive flow from a patent ductus arteriosus, and delayed antiplatelet initiation. The thoracotomy approach was protective. Risk factors for worse survival to the next stage included shunt thrombosis and perioperative platelet transfusion.

Conclusions

While complications remain common, our contemporary results demonstrate that SA-PA shunts remain a reliable palliation for CHD with insufficient pulmonary blood flow. Risk reduction may involve careful management of competitive pulmonary blood flow and prompt initiation of antiplatelet therapy.

Keywords

systemic-to-pulmonary shunt shunt failure staged repair

Get full access to this article

View all access options for this article.

References

Blalock

Taussig

. The surgical treatment of malformations of the heart: in which there is pulmonary stenosis or pulmonary atresia. J Am Med Assoc. 1945;128(3):189-202.

Mahajan

Ebenroth

Borsheim

, et al. Intermediate outcomes of staged tetralogy of Fallot repair. World J Pediatr Congenit Heart Surg. 2019;10(6):694-701.

Glatz

Petit

Goldstein

, et al. Comparison between patent ductus arteriosus stent and modified Blalock-Taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow. Circulation. 2018;137(6):589-601. doi:https://doi.org/10.1161/CIRCULATIONAHA.117.029987

Sasikumar

Hermuzi

Fan

, et al. Outcomes of Blalock-Taussig shunts in current era: a single center experience. Congenit Heart Dis. 2017;12(6):808-814. doi:https://doi.org/10.1111/chd.12516

Hill

Wallace

, et al. Shunt failure-risk factors and outcomes: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery database. Ann Thorac Surg. 2018;105(3):857-864. doi:https://doi.org/10.1016/j.athoracsur.2017.06.028

Gedicke

Morgan

Parry

Martin

Tulloh

. Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations. Heart Vessels. 2010;25(5):405-409. doi:https://doi.org/10.1007/s00380-009-1219-1

Santro

d'Udekem

Zannino

, et al. Determinants of acute events leading to mortality after shunt procedure in univentricular palliation. J Thorac Cardiovasc Surg. 2019;158(4):1144-1153 e6. doi:https://doi.org/10.1016/j.jtcvs.2019.03.126

Heidari-Bateni

Norouzi

Hall

Brar

Eghtesady

. Defining the best practice patterns for the neonatal systemic-to-pulmonary artery shunt procedure. J Thorac Cardiovasc Surg. 2014;147(3):869-873.e3.

The Society of Thoracic Surgeons - European Association for Cardio-Thoracic Surgery Congenital Heart Surgery Mortality Categories (STAT Mortality Categories). The Society of Thoracic Surgeons, European Association for Cardio-Thoracic Surgery. sts.org/sites/default/files/Database%20Manuals/Appendix%20C%620-%202022_5_5_2002.pdf. Accessed 4/28/2025.

10.

STS Congenital Heart Surgery Database Data Specifications Version 3.41. The Society of Thoracic Surgeons. April 30, 2024.

11.

Ambarsari

Purbojo

Blumauer

, et al. Systemic-to-pulmonary artery shunting using heparin-bonded grafts. Interact Cardiovasc Thorac Surg. 2018;27(4):591-597. doi:https://doi.org/10.1093/icvts/ivy100

12.

Hobbes

d'Udekem

Zannino

Konstantinov

Brizard

Brink

. Determinants of adverse outcomes after systemic-to-pulmonary shunts in biventricular circulation. Ann Thorac Surg. 2017;104(4):1365-1370. doi:https://doi.org/10.1016/j.athoracsur.2017.06.043

13.

Yow

Berezny

, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease. Circulation. 2007;116(3):293-297. doi:https://doi.org/10.1161/CIRCULATIONAHA.106.652172

14.

Wells

Batra

Monforte

Sintek

Starnes

. Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg. 2005;79(6):2072-2076.

15.

Vitanova

Leopold

Pabst von Ohain

, et al. Risk factors for failure of systemic-to-pulmonary artery shunts in biventricular circulation. Pediatr Cardiol. 2018;39(7):1323-1329. doi:https://doi.org/10.1007/s00246-018-1898-4

16.

Vitanova

Leopold

von Ohain

, et al. Reasons for failure of systemic-to-pulmonary artery shunts in neonates. Thorac Cardiovasc Surg. 2019;67(1):2-7. doi:https://doi.org/10.1055/s-0037-1621706

17.

Ashfaq

Soroya

Iyengar

Federman

Reemtsen

. Heparin-coated grafts reduce mortality in pediatric patients receiving systemic-to-pulmonary shunts. Pediatr Cardiol. 2018;39(3):473-477. doi:https://doi.org/10.1007/s00246-017-1776-5

18.

Dorobantu

Pandey

Sharabiani

, et al. Indications and results of systemic to pulmonary shunts: results from a national database. Eur J Cardiothorac Surg. 2016;49(6):1553-1563.

19.

Fenton

Siewers

Rebovich

Pigula

. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg. 2003;76(1):152-156.

20.

Bove

Vandekerckhove

Panzer

De Groote

De Wolf

Francois

. Disease-specific outcome analysis of palliation with the modified Blalock-Taussig shunt. World J Pediatr Congenit Heart Surg. 2015;6(1):67-74. doi:https://doi.org/10.1177/2150135114558690

21.

Dutta

Nathan

Emani

Ibla

. Perioperative hyper-coagulation and thrombosis: cost analysis after congenital heart surgery. Pediatr Cardiol. 2025;46(5):1328-1339. doi:https://doi.org/10.1007/s00246-024-03554-1

22.

Patregnani

Sochet

Zurakowski

, et al. Cardiopulmonary bypass reduces early thrombosis of systemic-to-pulmonary artery shunts. World J Pediatr Congenit Heart Surg. 2018;9(3):276-282. doi:https://doi.org/10.1177/2150135118755985

23.

Emani

Trainor

Zurakowski

, et al. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2014;148(3):810-816.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.51 MB

Outcomes and Predictors of Failure of Systemic-to-Pulmonary Shunts: Experience of a Single Institution Over 14 Years